In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I): ##STR00001## and pharmaceutically acceptable derivatives thereof, wherein R.sup.1, R.sup.2, R.sup.3, n, X and Y are as defined herein. The present invention also provides pharmaceutical compositions comprising a compound of formula (I) and a pharmaceutically acceptable carrier. The present invention further provides compounds capable of inhibiting histone deacetylatase activity and methods for treating disorders regulated by histone deacetylase activity (e.g., cancer and protozoal infections) comprising administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof. The present invention additionally provides methods for modulating the glucose-sensitive subset of genes downstream of Ure2p. The present invention also provides methods for preparing compounds of the invention.
Claims The invention claimed is: 1. A method for inhibiting histone deacetylase activity in a patient or a biological sample, comprising administering to said patient, or contacting said biological sample with an effective inhibitory amount of a compound having the structure (I): ##STR00133## and pharmaceutically acceptable derivatives thereof; wherein R.sup.1 is hydrogen, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; n is 1-5; R.sup.2 is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; X is --O--, --C(R.sup.2A).sub.2--, --S--, or --NR.sup.2A--, wherein R.sup.2A is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; or wherein two or more occurrences of R.sup.2 and R.sup.2A, taken together, form an alicyclic or heterocyclic moiety, or an aryl or heteroaryl moiety; R.sup.3 is an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; and Y is an aromatic moiety. 2. The method according to claim 1, wherein the histone deacetylase is HDAC1 or HDAC6. 3. The method according to claim 1, wherein: R.sup.1 is hydrogen, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; R.sup.2 is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; X is --O--, --C(R.sup.2A).sub.2--, --S--, or --NR.sup.2A--, wherein R.sup.2A is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; or wherein two or more occurrences of R.sup.2 and R.sup.2A, taken together, form an alicyclic or heterocyclic moiety, or an aryl or heteroaryl moiety; R.sup.3 is an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; and Y is an aryl, -(aliphatic)aryl, or -(heteroaliphatic)aryl moiety. 4. The method according to claim 1, wherein the compound has the structure as shown in formula (Ia): ##STR00134## 5. The method according to claim 1, wherein the compound has the structure as shown in formula (Ib): ##STR00135## 6. The method according to claim 1, wherein R.sup.3 represents a phenyl group substituted with a moiety having the structure --P-Q, the following groups do not occur simultaneously as defined: P is selected from the group consisting of substituted or unsubstituted C.sub.4-C.sub.8 alkylene, C.sub.4-C.sub.8 alkenylene, C.sub.4-C.sub.8 alkynylene, and --R-T-U--, wherein R and U are independently absent or represent a C.sub.2-C.sub.7 alkylene, a C.sub.2-C.sub.7 alkenylene, or a C.sub.2-C.sub.7 alkynylene, and T represents O, S or NR.sup.T, wherein R.sup.T represents hydrogen, lower alkyl, lower alkenyl, lower alkynyl, aralkyl, aryl or heterocyclyl; and Q is selected from the group consisting of: ##STR00136## and a boronic acid moiety; wherein W is O or S; V is O, S or --NR.sup.Vd, wherein R.sup.Vd is hydrogen, alkyl, alkoxycarbonyl, aryloxycarbonyl, alkylsulfonyl, arylsulfonyl, or aryl; R.sup.Va is hydrogen, alkyl, alkenyl, alkynyl, or aryl; R.sup.Vb is hydrogen, alkyl, aryl, alkoxy, aryloxy, amino, hydroxylamino, alkoxylamino or halogen; and R.sup.Vc is hydrogen, alkyl, aryl, hydroxyl, alkoxy, aryloxy or amino. 7. The method according to claim 1, wherein R.sup.3 represents a phenyl group substituted with a moiety having the structure --P-Q, the following groups do not occur simultaneously as defined: P is selected from the group consisting of: ##STR00137## and Q is selected from the group consisting of: ##STR00138## wherein W and R.sup.Va-d are as defined above; X.sup.1 is a good leaving group (e.g., diazo, halogen, a sulfate or sulfonate ester such as a tosylate or mesylate); R.sup.Ve is hydrogen, alkyl, aryl, alkoxy, aryloxy, halogen; and R.sup.Vf is hydrogen, alkyl or halogen. 8. The method according to claim 1, wherein Y is an aryl or heteroaryl moiety substituted with Z, wherein Z is hydrogen, --(CH.sub.2).sub.qOR.sup.Z, --(CH.sub.2).sub.qSR.sup.Z, --(CH.sub.2).sub.qN(R.sup.Z).sub.2, --C(.dbd.O)R.sup.Z, --C(.dbd.O)N(R.sup.Z).sub.2, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein q is 0-4, and wherein each occurrence of R.sup.Z is independently hydrogen, a protecting group, a solid support unit, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety. 9. The method according to claim 1, wherein Y is a substituted phenyl moiety and the compound has the structure (II): ##STR00139## wherein Z is hydrogen, --(CH.sub.2).sub.qOR.sup.Z,--(CH.sub.2).sub.qSR.sup.Z, --(CH.sub.2).sub.qN(R.sup.Z).sub.2,--C(.dbd.O)R.sup.Z,--C(.dbd.O)N(R.sup.- Z).sub.2, or an alkyl, heteroalkyl, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety, wherein q is 0-4, and wherein each occurrence of R.sup.Z is independently hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 10. The method according to claim 1, wherein Y is a substituted phenyl moiety and the compound has the structure (III): ##STR00140## wherein R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 11. The method according to claim 1, wherein Y is a substituted phenyl moiety and X is S and the compound has the structure (IV): ##STR00141## wherein R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 12. The method according to claim 1, wherein Y is a substituted phenyl moiety and X is --NR.sup.2A and the compound has the structure (V): ##STR00142## wherein R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 13. The method according to claim 1, wherein Y is a substituted phenyl moiety and X is --O-- and the compound has the structure (VI): ##STR00143## wherein R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 14. The method according to claim 1, wherein Y is a substituted phenyl moiety and R.sup.3 is a phenyl moiety substituted with R.sup.4 and the compound has the structure (VII): ##STR00144## wherein R.sup.4 is --(CH.sub.2).sub.rN(R.sup.4A).sub.2, --(CH.sub.2).sub.rSR.sup.4A, --(CH.sub.2).sub.rOR.sup.4A, --(CH.sub.2).sub.rNR.sup.4AC(.dbd.O)R.sup.4B, --(CH.sub.2).sub.rC(.dbd.O)N(R.sup.4A).sub.2, --S(O).sub.2R.sup.4A, or is an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein each occurrence of R.sup.4B is independently hydrogen, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; and each occurrence of R.sup.4A is independently hydrogen, a protecting group, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, or is --C(.dbd.O)CH(R.sup.4C)NH(SO.sub.2)R.sup.4D, --SO.sub.2R.sup.4C, --C(.dbd.O)R.sup.4C, --C(.dbd.O)N(R.sup.4C).sub.2, --C(.dbd.S)N(R.sup.4C).sub.2, or --C(.dbd.O)(CH.sub.2).sub.tC(.dbd.O)NHR.sup.4C, wherein each occurrence of R.sup.4C and R.sup.4D is independently hydrogen, a protecting group, hydroxyl, protected hydroxyl, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein r and t are each independently 0-5; and Z is hydrogen, --(CH.sub.2).sub.qOR.sup.Z, --(CH.sub.2).sub.qSR.sup.Z, --CH.sub.2),.sub.qN(R.sup.Z).sub.2, --C(.dbd.O)R.sup.Z, --C(.dbd.O)N(R.sup.Z).sub.2, or an alkyl, heteroalkyl, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety, wherein q is 0-4, and wherein each occurrence of R.sup.Z is independently hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 15. The method according to claim 14, wherein Z is --CH.sub.2OR.sup.Z, and the compound has the structure (VIII): ##STR00145## wherein R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -heteroalkyl)heteroaryl moiety. 16. The method according to claim 1, wherein R.sup.1 is hydrogen, methyl, or phenyl. 17. The method according to claim 1, wherein X--R.sup.2 has one of the structures: ##STR00146## ##STR00147## ##STR00148## ##STR00149## 18. The method according to claim 1, wherein R.sup.3 is one of the following structures: ##STR00150## wherein L is a substituted or unsubstituted C.sub.4-8alkylene or C.sub.4-8alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1,NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl; and R.sup.4A comprises a metal chelator. 19. The method according to claim 18, wherein L is --(CH.sub.2).sub.rN(R.sup.4C)Alk.sup.1-, wherein r is 0 or 1; R.sup.4C is hydrogen, a nitrogen protecting group, alkyl, acyl, heteroalkyl, aryl or heteroaryl; and Alk.sup.1 is a substituted or unsubstituted C.sub.3-7alkylene or C.sub.3-7alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 20. The method according to claim 18, wherein L is --(CH.sub.2).sub.rN(R.sup.4C)C(.dbd.O)Alk.sup.2-, wherein r is 0 or 1; R.sup.4C is hydrogen, a nitrogen protecting group, alkyl, acyl, heteroalkyl, aryl or heteroaryl; and Alk.sup.2 is a substituted or unsubstituted C.sub.3-6alkylene or C.sub.3-6alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 21. The method according to claim 18, wherein L is --(CH.sub.2).sub.rNHC(.dbd.O)(CH.sub.2).sub.t--, wherein r is 0 or 1; and t is 3, 4, 5 or 6. 22. The method according to any one of claims 18-21, wherein R.sup.4A is --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00151## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 23. The method according to claim 1, wherein the compound has the structure: ##STR00152## wherein R.sup.4 is --(CH.sub.2).sub.rN(R.sup.4A).sub.2, --(CH.sub.2),SR.sup.4A, --(CH.sub.2).sub.rOR.sup.4A, --(CH.sub.2).sub.rNR.sup.4AC(.dbd.O)R.sup.4B, --(CH.sub.2).sub.rC(.dbd.O)N(R.sup.4A).sub.2, --S(O).sub.2R.sup.4A, or is an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein each occurrence of R.sup.4B is independently hydrogen, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; and each occurrence of R.sup.4A is independently hydrogen, a protecting group, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, or is --C(.dbd.O)CH(R.sup.4C)NH(SO.sub.2)R.sup.4D, --SO.sub.2R.sup.4C, --C(.dbd.O)R.sup.4C, --C(.dbd.O)N(R.sup.4C).sub.2, --C(.dbd.S)N(R.sup.4C).sub.2, or --C(.dbd.O)(CH.sub.2).sub.tC(.dbd.O)NHR.sup.4C, wherein each occurrence of R.sup.4C and R.sup.4D is independently hydrogen, a protecting group, hydroxyl, protected hydroxyl, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein r and t are each independently 0-5; and R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 24. The method according to claim 23, wherein R.sup.1 is hydrogen, phenyl or methyl, R.sup.Z is hydrogen or a solid support unit; R.sup.2 is a substituted or unsubstituted alkyl or heteroalkyl moiety, or a substituted or unsubstituted aryl or heteroaryl moiety; and R.sup.4 is --(CH.sub.2).sub.rN(R.sup.4A).sub.2, --(CH.sub.2).sub.rSR.sup.4A, --(CH.sub.2).sub.rOR.sup.4A, --(CH.sub.2).sub.rNR.sup.4AC(.dbd.O)R.sup.4B, --(CH.sub.2).sub.rC(.dbd.O)N(R.sup.4A).sub.2, --S(O).sub.2R.sup.4A, or is an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein each occurrence of R.sup.4B is independently hydrogen, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; and each occurrence of R.sup.4A is independently hydrogen, a protecting group, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, or is --C(.dbd.O)CH(R.sup.4C)NH(SO.sub.2)R.sup.4D, --SO.sub.2R.sup.4C, --C(.dbd.O)R.sup.4C, --C(.dbd.O)N(R.sup.4C).sub.2, --C(.dbd.S)N(R.sup.4C).sub.2, or --C(.dbd.O)(CH.sub.2).sub.tC(.dbd.O)NHR.sup.4C, wherein each occurrence of R.sup.4C and R.sup.4D is independently hydrogen, a protecting group, hydroxyl, protected hydroxyl, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein r and t are each independently 0-5. 25. The method according to claim 23, wherein R.sup.4 represents a moiety having the structure -L-R.sup.4A and the compound has the structure: ##STR00153## wherein L is a linker and R.sup.4A comprises a metal chelator. 26. The method according to claim 25, wherein L is a substituted or unsubstituted C.sub.4-8alkylene or C.sub.4-8alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 27. The method according to claim 26, wherein L is --(CH.sub.2).sub.rNHC(.dbd.O)(CH.sub.2).sub.t--, wherein r is 0 or 1; and t is 3, 4, 5 or 6. 28. The method according to claim 25, wherein R.sup.4A is --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00154## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 29. The method according to claim 25, wherein the compound has the structure: ##STR00155## wherein r is 0 or 1; Alk.sup.1 is a substituted or unsubstituted C.sub.4-7alkylene or C.sub.4-7alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl; R.sup.4A comprises a metal chelator; and R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 30. The method according to claim 29, wherein Alk.sup.1 is a moiety having the structure --C(.dbd.O)-Alk.sup.2- and the compound has the structure: ##STR00156## wherein Alk.sup.2 is a substituted or unsubstituted C.sub.3-6alkylene or C.sub.3-6alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 31. The method according to claim 30, wherein Alk.sup.2 is a substituted or unsubstituted C.sub.3-6alkylene chain. 32. The method according to claim 30, wherein R.sup.4A is --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00157## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 33. The method according to claim 29, wherein the compound has the structure: ##STR00158## wherein s is an integer from 2-5; w is an integer from 0-4; R.sup.4A comprises a metal chelator and each occurrence of R.sup.4D is independently hydrogen, alkyl, heteroalkyl, cycloalkyl, heterocyclic, alkenyl, alkynyl, aryl, heteroaryl, halogen, CN, NO.sub.2, or WR.sup.W1 wherein W is O, S, NR.sup.W2, --C(.dbd.O), --S(.dbd.O), --SO.sub.2, --C(.dbd.O)O--, --OC(.dbd.O), --C(.dbd.O)NR.sup.W2, --NR.sup.W2C(.dbd.O); wherein each occurrence of R.sup.W1 and R.sup.W2 is independently hydrogen, a protecting group, a prodrug moiety or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl or heteroaryl moiety, or, when W is NR.sup.W2, R.sup.W1 and R.sup.W2, taken together with the nitrogen atom to which they are attached, form a heterocyclic or heteroaryl moiety; or any two adjacent occurrences of R.sup.2B, taken together with the atoms to which they are attached, form a substituted or unsubstituted, saturated or unsaturated alicyclic or heterocyclic moiety, or a substituted or unsubstituted aryl or heteroaryl moiety. 34. The method according to claim 33, wherein R.sup.4A is --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00159## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 35. The method according to claim 1, wherein the compound has the structure: ##STR00160## wherein R.sup.4 is --(CH.sub.2).sub.rN(R.sup.4A).sub.2, --(CH.sub.2).sub.rSR.sup.4A, --(CH.sub.2).sub.rOR.sup.4A, --(CH.sub.2).sub.rNR.sup.4AC(.dbd.O)R.sup.4B, --(CH.sub.2).sub.rC(.dbd.O)N(R.sup.4A).sub.2, --S(O).sub.2R.sup.4A, or is an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein each occurrence of R.sup.4B is independently hydrogen, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; and each occurrence of R.sup.4A is independently hydrogen, a protecting group, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, or is --C(.dbd.O)CH(R.sup.4c)NH(SO.sub.2)R.sup.4D, --SO.sub.2R.sup.4C, --C(.dbd.O)R.sup.4C, --C(.dbd.O)N(R.sup.4C).sub.2, --C(.dbd.S)N(R.sup.4C).sub.2, or --C(.dbd.O)(CH.sub.2).sub.tC(.dbd.O)NHR.sup.4C, wherein each occurrence of R.sup.4C and R.sup.4D is independently hydrogen, a protecting group, hydroxyl, protected hydroxyl, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein r and t are each independently 0-5; R.sup.2A is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aryl or heteroaryl moiety; and R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 36. The method according to claim 35, wherein R.sup.1 is hydrogen, phenyl or methyl, R.sup.Z is hydrogen or a solid support unit; R.sup.2 is a substituted or unsubstituted alkyl or heteroalkyl moiety, or a substituted or unsubstituted aryl or heteroaryl moiety; either or both of R.sup.2 and R.sup.2A, or R.sup.2 and R.sup.2A taken together with the nitrogen atom to which they are attached, forms a substituted or unsubstituted cycloalkyl or heterocyclic moiety, or a substituted or unsubstituted aryl or heteroaryl moiety; and R.sup.4 is --(CH.sub.2).sub.rN(R.sup.4A).sub.2, --(CH.sub.2).sub.rSR.sup.4A, --(CH.sub.2)OR.sup.4A, --(CH.sub.2).sub.rNR.sup.4AC(.dbd.O)R.sup.4B, --(CH.sub.2).sub.rC(.dbd.O)N(R.sup.4A).sub.2, --S(O).sub.2R.sup.4A, or is an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein each occurrence of R.sup.4B is independently hydrogen, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety; and each occurrence of R.sup.4A is independently hydrogen, a protecting group, an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, or is --C(.dbd.O)CH(R.sup.4C)NH(SO.sub.2)R.sup.4D, --SO.sub.2R.sup.4C, --C(.dbd.O)R.sup.4C, --C(.dbd.O)N(R.sup.4C).sub.2, --C(.dbd.S)N(R.sup.4C).sub.2, or --C(.dbd.O)(CH.sub.2).sub.tC(.dbd.O)NHR.sup.4C, wherein each occurrence of R.sup.4C and R.sup.4D is independently hydrogen, a protecting group, hydroxyl, protected hydroxyl, or an aliphatic, alycyclic, heteroaliphatic, heterocyclic, aryl, heteroaryl, -(aliphatic)aryl, -(aliphatic)heteroaryl, -(heteroaliphatic)aryl, or -(heteroaliphatic)heteroaryl moiety, wherein r and t are each independently 0-5. 37. The method according to claim 35, wherein R.sup.4 represents a moiety having the structure -L-R.sup.4A and the compound has the structure: ##STR00161## wherein L is a linker and R.sup.4A comprises a metal chelator. 38. The method according to claim 37, wherein L is a substituted or unsubstituted C.sub.4-8alkylene or C.sub.4-8alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 39. The method according to claim 38, wherein L is --(CH.sub.2).sub.rNHC(.dbd.O)(CH.sub.2).sub.t--, wherein r is 0 or 1; and t is 3, 4, 5 or 6. 40. The method according to claim 37, wherein R.sup.4Ais --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00162## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 41. The method according to claim 35, wherein the compound has the structure: ##STR00163## wherein r is 0 or 1; Alk.sup.1 is a substituted or unsubstituted C.sub.4-7alkylene or C.sub.4-7alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl; R.sup.4A comprises a metal chelator; and R.sup.Z is hydrogen, a protecting group, a solid support unit, or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl, heteroaryl, -(alkyl)aryl, -(alkyl)heteroaryl, -(heteroalkyl)aryl, or -(heteroalkyl)heteroaryl moiety. 42. The method according to claim 41, wherein Alk.sup.1 is a moiety having the structure --C(.dbd.O)-Alk.sup.2- and the compound has the structure: ##STR00164## wherein Alk.sup.2 is a substituted or unsubstituted C.sub.3-6alkylene or C.sub.3-6alkenylene chain wherein up to two non-adjacent methylene units are independently optionally replaced by CO, CO.sub.2, COCO, CONR.sup.Z1, OCONR.sup.Z1, NR.sup.Z1NR.sup.Z2, NR.sup.Z1NR.sup.Z2CO, NR.sup.Z1CO, NR.sup.Z1CO.sub.2, NR.sup.Z1CONR.sup.Z2, SO, SO.sub.2, NR.sup.Z1SO.sub.2, SO.sub.2NR.sup.Z1, NR.sup.Z1SO.sub.2NR.sup.Z2, O, S, or NR.sup.Z1; wherein each occurrence of R.sup.Z1 and R.sup.Z2 is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 43. The method according to claim 42, wherein Alk.sup.2 is a substituted or unsubstituted C.sub.3-6alkylene chain. 44. The method according to claim 42, wherein R.sup.4A is --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00165## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 45. The method according to claim 35, wherein the compound has the structure: ##STR00166## wherein s is an integer from 2-5; w is an integer from 0-4; R.sup.4A comprises a metal chelator and each occurrence of R.sup.4D is independently hydrogen, alkyl, heteroalkyl, cycloalkyl, heterocyclic, alkenyl, alkynyl, aryl, heteroaryl, halogen, CN, NO.sub.2, or WR.sup.W1 wherein W is O, S, NR.sup.W2, --C(.dbd.O), --S(.dbd.O), --SO.sub.2, --C(.dbd.O)O--, --OC(.dbd.O), --C(.dbd.O)NR.sup.W2, --NR.sup.W2C(.dbd.O); wherein each occurrence of R.sup.W1 and R.sup.W2 is independently hydrogen, a protecting group, a prodrug moiety or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl or heteroaryl moiety, or, when W is NR.sup.W2, R.sup.W1 and R.sup.W2, taken together with the nitrogen atom to which they are attached, form a heterocyclic or heteroaryl moiety; or any two adjacent occurrences of R.sup.2B, taken together with the atoms to which they are attached, form a substituted or unsubstituted, saturated or unsaturated alicyclic or heterocyclic moiety, or a substituted or unsubstituted aryl or heteroaryl moiety. 46. The method according to claim 45, wherein R.sup.4A is --C(.dbd.O)OR.sup.4B, --C(.dbd.O)NHOR.sup.4B or a moiety having the structure: ##STR00167## wherein each occurrence of R.sup.4B is independently hydrogen, alkyl, heteroalkyl, aryl, heteroaryl or acyl. 47. The method according to any one of claim 1, 23, 33, 35, or 45, wherein R.sup.2 is one of the following structures: ##STR00168## ##STR00169## ##STR00170## wherein m and p are each independently integers from 0 to 3; q.sub.1 is an integer from 1 to 6; R.sup.2C is hydrogen, lower alkyl, aryl or a nitrogen protecting group; R.sup.2D is hydrogen or lower alkyl; and each occurrence of R.sup.2B is independently hydrogen, halogen, --CN, --COOH, NO.sub.2, alkyl, heteroalkyl, aryl, heteroaryl, or WR.sup.W1 wherein W is O, S, NR.sup.W2, --C(.dbd.O), --S(.dbd.O), --SO.sub.2, --C(.dbd.O)O--, --OC(.dbd.O), --C(.dbd.O)NR.sup.W2, --NR.sup.W2C(.dbd.O); wherein each occurrence of R.sup.W1 and R.sup.W2 is independently hydrogen, a protecting group, a prodrug moiety or an alkyl, cycloalkyl, heteroalkyl, heterocyclic, aryl or heteroaryl moiety, or, when W is NR.sup.W2, R.sup.W1 and R.sup.W2, taken together with the nitrogen atom to which they are attached, form a heterocyclic or heteroaryl moiety; or any two adjacent occurrences of R.sup.2B, taken together with the atoms to which they are attached, form a substituted or unsubstituted, saturated or unsaturated alicyclic or heterocyclic moiety, or a substituted or unsubstituted aryl or heteroaryl moiety. 48. The method according to claim 35 or 45, wherein either or both of R.sup.2, R.sup.2A, or R.sup.2 and R.sup.2A, taken together with the nitrogen atom to which they are attached comprise ##STR00171## wherein k is an integer from 0-3; A-B, B-D, D-E, E-G, G-J, two or more occurrences of J, and J-A are each connected by a single or double bond; A is CH, C, or N; B is CR.sup.B, C(R.sup.B).sub.2, C(.dbd.O), NR.sup.B, N, O or S; D is CR.sup.D, C(R.sup.D).sub.2, C(.dbd.O), NR.sup.D, N, O or S; E is CR.sup.E, C(R.sup.E).sub.2, C(.dbd.O), NR.sup.E, N, O or S; G is CR.sup.G, C(R.sup.G).sub.2, C(.dbd.O), NR.sup.G, N, O or S; and each occurrence of J is independently CR.sup.J, C(R.sup.J).sub.2, C(.dbd.O), NR.sup.J, N, O or S; wherein each occurrence of R.sup.B, R.sup.D, R.sup.E, R.sup.G and R.sup.J is independently hydrogen, halogen, hydroxyl, protected hydroxyl, thiol, protected thiol, amino, protected amino, --COOH, --CONH.sub.2, --NHCOOH, --NHCOO(alkyl), --NHCO(alkyl), or a substituted or unsubstituted, cyclic or acyclic, linear or branched alkyl or heteroalkyl moiety, or a substituted or unsubstituted aryl or heteroaryl moiety, or any two or R.sup.B, R.sup.D, R.sup.E, R.sup.G or R.sup.J taken together comprises a substituted or unsubstituted alicyclic or heterocyclic, moiety or a substituted or unsubstituted aryl or heteroaryl moiety. 49. The method according to claim 35 or 45, wherein one or both of R.sup.2 and R.sup.2A is an aryl or heteroaryl moiety substituted with --COOH, halogen, alkyl, heteroalkyl, aryl, heteroaryl, OH, SH, NO.sub.2, NH.sub.2, or --NHC(.dbd.O)alkyl. 50. The method according to claim 33 or 45, wherein R.sup.4A is --C(.dbd.O)OH, --C(.dbd.O)NHOH or a moiety having the structure: ##STR00172## 51. The method according to claim 33 or 45, wherein R.sup.4A is --C(.dbd.O)NHOH. 52. The method according to claim 1, wherein the compound has the structure: ##STR00173## 53. The method according to claim 1, wherein the compound has the structure: ##STR00174## 54. The method according to any one of claim 1, 23, 33, 35, or 45, wherein the biological sample is a cell. 55. A method for inhibiting histone deacetylase activity in a cell comprising contacting a cell with a compound having the structure (I): ##STR00175## and pharmaceutically acceptable derivatives thereof; wherein R.sup.1 is hydrogen, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; n is 1-5; R.sup.2 is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; X is --O--, --C(R.sup.2A).sub.2--, --S--, or --NR.sup.2A--, wherein R.sup.2A is hydrogen, a protecting group, or an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; or wherein two or more occurrences of R.sup.2 and R.sup.2A, taken together, form an alicyclic or heterocyclic moiety, or an aryl or heteroaryl moiety; R.sup.3 is an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aromatic or heteroaromatic moiety; and Y is an aromatic moiety. 